{"Name":"Penumbra","perma":"penumbra","BasicInfo":{"funded":"2004-01-01","isClosed":false,"closed":null,"short":"Penumbra develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases."},"FundingRounds":[{"funding_type":"seed","series":null,"announcedDate":"2012-11-02","moneyRaised":121230}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NYSE","symbol":"PEN","shares":null,"date":"2015-09-18","openPrice":null,"moneyRaised":120000000,"valuation":null},"Investments":[],"Products":[],"CurrentTeam":[{"title":"President","started":null,"ended":null,"firstName":"James","lastName":"Pray"},{"title":"Chief Financial Officer","started":null,"ended":null,"firstName":"Lynn","lastName":"Rothman"},{"title":"Co-Founder","started":null,"ended":null,"firstName":"Adam","lastName":"Elsesser"},{"title":"Co-Founder","started":null,"ended":null,"firstName":"Arani","lastName":"Bose"}],"PastTeam":[]}
